Skip to main content
. 2021 Jul 14;107(21):1748–1755. doi: 10.1136/heartjnl-2021-319229

Table 2.

Characteristics of all medication prescriptions in the study population

Women
(n=1276)
Men
(n=1492)
Medication group, n (%)
 ACEI/ARB 619 (48.5) 724 (48.5)
 Beta blocker 571 (44.7) 644 (43.2)
 MRA 86 (6.7) 124 (8.3)
Target dose group, n (%)
 1%–49% 564 (44.2) 654 (43.8)
 50%–99% 513 (40.2) 608 (40.8)
 100% or higher 199 (15.6) 230 (15.4)
Median target dose baseline prescriptions (IQR)
 ACEI/ARB 50 (25.0–66.70) 50 (25.00–57.10)
 Beta blocker 25 (25.00–50.00) 25 (25.00–50.00)
 MRA 50 (50.00–50.00) 50 (50.00–50.00)

ACEI, ACE inhibitor; ARB, angiotensin-receptor blocker; MRA, mineralocorticoid receptor antagonist.